Related Experiment Video
Updated: Aug 4, 2025

07:03
Evaluation of Hemisphere Lateralization with Bilateral Local Field Potential Recording in Secondary Motor Cortex of Mice
Published on: July 31, 2019
6.8K
Elevated Gaussian-modeled beta power in the cortex characterizes aging, but not Parkinson's disease
Apoorva Karekal1, Samuel Stuart2, Martina Mancini3
1Department of Human Physiology, University of Oregon, Eugene, Oregon, United States.
Journal of Neurophysiology
|April 5, 2023
Summary
Aging, not Parkinson's disease (PD), elevates cortical beta power. This study found higher beta power in older adults compared to younger adults, but not in individuals with PD. Beta oscillations are key in brain networks.
Area of Science:
- Neuroscience
- Aging Research
- Parkinson's Disease Research
Background:
- Aging is a primary risk factor for Parkinson's disease (PD).
- PD is associated with excessive beta oscillations (13-30 Hz) in brain networks.
- Cortical beta power is not consistently elevated in individuals with PD.
Purpose of the Study:
- To investigate differences in resting cortical beta power among younger controls, older controls, and individuals with PD.
- To determine if a novel Gaussian model for quantifying beta power can differentiate these groups.
- To examine the distribution of beta power across the cortex.
Main Methods:
- Scalp electroencephalogram (EEG) was used to record brain activity.
- A novel Gaussian model was applied to quantify sensorimotor beta power.
- Analysis included comparing beta power across younger controls, older controls, and individuals with PD, and examining the entire cortical distribution.
Main Results:
- Gaussian-modeled sensorimotor beta power did not differentiate individuals with PD (on medication) from healthy younger or older controls.
- Beta power, but not theta or alpha power, was significantly higher in healthy older adults compared to younger adults, particularly in frontal and parietal regions.
- The aperiodic component's exponent was higher in younger controls than in individuals with PD in the right parietal-occipital region.
Conclusions:
- Resting cortical beta power, quantified using a Gaussian model, is elevated in aging but does not distinguish individuals with PD from healthy controls.
- Age, rather than PD, appears to be a significant modulator of cortical beta power.
- Further longitudinal studies are warranted to explore the relationship between increasing age and sensorimotor beta power.
Related Concept Videos
Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K
Brain Waves
1.7K
Brain waves are electrical signals generated by the neurons in the brain, which are regularly monitored to measure mental activities. Brain waves and their frequency ranges can be measured using an electroencephalogram or EEG. There are four main types of brain waves, each with distinct characteristics:
1.7K
Parkinson's Disease: Overview
632
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
632
Alzheimer's Disease: Overview
557
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
557

